Express Pharma - Page 377 of 2181 - Express Pharma

Lupin receives US FDA approval for Dapagliflozin tablets

Inventia enters the U.S. market with FDA approved Dapagliflozin tablets

Biocon launches Bosaya and Aukelso in the United States

MSN Group launches Fesobig to treat urinary incontinence and overactive bladder

SARS-CoV-2 Omicron XBB.1.5 variant is highly transmissible and infectious: Study

Long road ahead for non-statin therapies in Australia dyslipidemia treatment space: GlobalData

Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis

Pfizer agrees to revise COVID vaccine contract with EU: Reports

Glenmark gets ANDA approval for Clindamycin Hydrochloride Capsules

Cingulate and Indegene sign agreement for lead ADHD candidate CTx-1301

New RSV therapies may accelerate the emergence of drug-resistant strains: GlobalData

IIL, ICAR-CIFA sign pact to develop vaccine against hemorrhagic septicemia in freshwater fishes

Tough market conditions fail to deter discussions about R&D investments, new technologies: GlobalData